Abstracts

General Guidelines
Abstracts should contain the following four components:

Background: a concise statement of the issue under investigation or a hypothesis;
Materials & Methods: the experimental methods used (including the statistical analyses employed);
Results: specific findings (promises such as "to be completed" or "to be presented" are not acceptable);
Conclusions: a summary of findings that are supported by your results (statistical analyses used to support the conclusions, where appropriate, should be included; concluding statements such as "the results will be discussed" are not acceptable).

Please note that abstracts cannot be accepted if tables and graphs are included.
The maximum word count for the abstract body is 500 words.
 
Abstracts are considered official communications to the conference and will be treated confidentially. For those abstracts that are accepted, submitters agree to attend the meeting and present their abstract as scheduled.

Abstract submission
Authors can submit their abstracts electronically per 1 December 2009, using the button on the right hand side. This will direct you to the appropriate web page.

Please follow the step-by-step directions to upload the abstract. To ensure that your abstract retains any special characters or formatting, the abstract must be in Microsoft Word format.

Categories for abstract submission
For purposes of review and programming, abstracts are divided into topical categories. Selection of the most appropriate category is important as it determines who reviews your abstract. The Program Committee reserves the right to reassign your abstract to a more appropriate category. 

Topics:
- Pharmacokinetics and Pharmacodynamics of Drug Efficacy and Toxicity
- Pharmacokinetics in Special Populations
- Therapeutic Drug Monitoring
- Drug Interactions 
- Ethno-Pharmacology (ethnicity related Pharmacology)
- Pharmacogenetics
- Advanced Investigations in Pharmacology: Protein Binding, Intracellular Drug
  Concentrations, and Compartmental Pharmacokinetics
- Novel Drug Formulations
- Drug Development Science

Notification of abstract acceptance and presentation format
Notifications of acceptance and format of presentation (oral or poster presentation) will be e-mailed to submitting authors in the second half of February.
It is the responsibility of the corresponding/presenting author to inform all co-authors of the abstract’s status. Please notify the Conference Secretariat if you have not received notification by the beginning of March.

If an abstract is accepted, one author is required to register for the conference and present the paper as scheduled. Guidelines for preparing your oral and/or poster presentations will be sent after your abstract has been accepted.

Abstract publication
Accepted abstracts will be published in the Final Program and Abstract Book, which will be distributed during the conference. In addition, all abstracts will be published in the journal Reviews in Antiviral Therapy.
Please note that the conference secretariat cannot be held responsible for any typing or language errors in the submitted abstracts as only the format of the abstracts will be changed and not the content.